A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours
Gillessen S, Speiser D, Laurent J, Kramer D, Liedert B, Mattiacci M, Omlin A, Sessa C, Beck J, Gallerani E, Gnad-Vogt U, Stupp R. A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours. Eur J Cancer 2012; 49:35-44.
20.08.2012
A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours
20.08.2012
Eur J Cancer 2012; 49:35-44
Gillessen Silke, Speiser Daniel E, Laurent Julien, Kramer Daniel, Liedert Bernd, Mattiacci Maria R, Omlin Aurelius, Sessa Cristiana, Beck Joachim, Gallerani Elisa, Gnad-Vogt Ulrike S, Stupp Roger
Weiter
